RIEDEL NORBERT G reported 1 transaction at ETON PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/5/2026ACC: 0001437749-26-003230
Director
Since Nov 2018
0.00
Net shares
Net seller
$132.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
30K acquired · 30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
$4.42
Trade value
$132.60K
% of position
600.0%
2/3/2026
5K→35K
Total
Net shares
+30K
Net value
$132.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | X · X | +30K | $4.42 | $132.60K | 600.0% | 5K | 35K |
| Total | +30K | $132.60K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
4.42
Held after
0.00
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock30K shares | 2/3/2026 | X · X | −30K | 4.42 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned157.15K
Total
157.15K indirect157.15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 157.15K | Indirect |
| Total | 157.15K | 157.15K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported